Alliance A031501: Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (MIBC) (AMBASSADOR) vs Observation
   Google Scholar   
Citation:
J Clin Oncol vol 37 (suppl 7S) abstr TPS504
Meeting Instance:
ASCO GU 2019
Year:
2019
Type:
Abstract
Sub type:
Poster Discussion
Funding:
NCTN
Endpoint:
No-Endpoint
Analysis:
Trial-Description-Only
Status:
Presented/Published
Citation Status:
epreprint
Note:
Methodological:
No
Biospecimen:
Yes
DataSharing:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GU
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, Merck  
Corr. Author:
 
Authors:
                       
Primary Study
A031501
Secondary Studies:
Phases:
3
Keywords: